According to the latest report by IMARC Group, titled “Ambulatory Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global ambulatory services market size reached US$ 3.5 Trillion in 2022. Ambulatory services refer to a set of clinical, diagnostic, therapeutic, and medical services that are performed without admission to a hospital. They include medical laboratories, home healthcare facilities, and registered doctors and professionals from ophthalmology, orthopedics, plastic surgery, pain, gynecology, and gastroenterology specialties. Ambulatory services offer diagnosis, observation, consultation, treatment, intervention, rehabilitation, and emergency services to patients by utilizing advanced medical solutions on an outpatient basis. Apart from this, these services reduce the need for hospital stays, save time, lower medical bills, deliver personalized care, and allow doctors to operate certain surgeries outside hospital operating rooms (ORs). As a result, ambulatory services are extensively used by hospitals to enable better management and prevention of chronic diseases and enhance the health of individuals by providing improved clinical outcomes.
Global Ambulatory Services Market Trends:
The Increasing demand for ambulatory services to meet the constantly evolving medical needs represents one of the key factors driving the market growth. In line with this, the rising prevalence of various chronic and cardiovascular disorders (CVDs), especially amongst the geriatric population, and the escalating incidences of hospital readmissions are facilitating the market growth. Additionally, the increasing acceptance of ambulatory services due to their minimal cost of care, predictable scheduling, easy accessibility, flexible timings, and the capability to deliver a better diagnosis, prognosis, and treatments to patients are favoring the market growth. Moreover, the expanding demand for minimally invasive (MI) surgeries, preventive healthcare, and diagnostic modalities, including blood tests, X-rays, endoscopy, and biopsy procedures of external organs, is impelling the market growth. Furthermore, the implementation of favorable initiatives and investments by governments of several countries to optimize the healthcare infrastructure are propelling the market growth. Besides this, the escalating need for quality treatment facilities and employment of computerized prescription systems, electronic health records (EHRs), and mobile health (mHealth) to ensure instant medical attention are supporting the market growth. Other factors, such as significant enhancements in the healthcare sector and the emergence of effective alternative treatments, are creating a positive outlook for the market. Looking forward, the market value is projected to reach US$ 5.1 Trillion by 2028, expanding at a CAGR of 6.2% during 2023-2028.
- On the basis of the service type, the market is segregated into diagnosis, observation and consultation, treatment, wellness, and rehabilitation.
- Based on the department, the market is categorized into primary care offices, outpatient departments, emergency departments, surgical specialty, and medical specialty.
- On a regional basis, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and Middle East and Africa.
- The competitive landscape of the market has also been examined, with some of the key players being Envision Healthcare, HCA Healthcare, Healthway Medical Corporation Limited, Medical Facilities Corporation, Nueterra Capital, Surgery Partners, Surgical Care Affiliates Inc. (UnitedHealth Group Incorporated), Tenet Healthcare Corporation, Terveystalo Oyj and Universal Health Services Inc.
|Base Year of the Analysis
||Service Type, Department, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Envision Healthcare, HCA Healthcare, Healthway Medical Corporation Limited, Medical Facilities Corporation, Nueterra Capital, Surgery Partners, Surgical Care Affiliates Inc. (UnitedHealth Group Incorporated), Tenet Healthcare Corporation, Terveystalo Oyj and Universal Health Services Inc.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800